The next ten stories on antiviral drug discovery (part E): advents, advances, and adventures.

Article Details

Citation

Copy to clipboard

De Clercq E

The next ten stories on antiviral drug discovery (part E): advents, advances, and adventures.

Med Res Rev. 2011 Jan;31(1):118-60. doi: 10.1002/med.20179.

PubMed ID

19844936 [ View in PubMed

]

Abstract

This review article presents the fifth part (part E) in the series of stories on antiviral drug discovery. The ten stories belonging to this fifth part are dealing with (i) aurintricarboxylic acid; (ii) alkenyldiarylmethanes; (iii) human immunodeficiency virus (HIV) integrase inhibitors; (iv) lens epithelium-derived growth factor as a potential target for HIV proviral DNA integration; (v) the status presens of neuraminidase inhibitors NAIs in the control of influenza virus infections; (vi) the status presens on respiratory syncytial virus inhibitors; (vii) tricyclic (1,N-2-ethenoguanine)-based acyclovir and ganciclovir derivatives; (viii) glycopeptide antibiotics as antivirals targeted at viral entry; (ix) the potential (off-label) use of cidofovir in the treatment of polyoma (JC and BK) virus infections; and (x) finally, thymidine phosphorylase as a target for both antiviral and anticancer agents.

DrugBank Data that Cites this Article

Drug Enzymes

Drug	Enzyme	Kind	Organism	Pharmacological Action	Actions
Cidofovir	Thymidine phosphorylase	Protein	Humans	Unknown	Inhibitor	Details